Obsidian Therapeutics, Inc. Common Stock (OBX NASDAQ) stock market data APIs
$17.7064
-0.32(-1.8%)
as of September 11, 2026
Try our APIs with
free plan!
Obsidian Therapeutics, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies. The company is developing investigational therapies, including OBX-115, which is being evaluated in clinical trials for advanced solid tumors, advanced melanoma, and relapsed refractory non-small cell lung cancer. It utilizes a proprietary Cytodriver technology platform designed to regulate protein function using FDA-approved small-molecule drugs and is advancing tumor-infiltrating lymphocyte (TIL) cell therapies that leverage mbIL15 to enhance persistence, antitumor activity, and clinical safety. Access to investigational therapies is currently limited to participation in clinical trials, and the company collaborates with other organizations to apply its platform technology. The company was founded in 2015 and is based in Cambridge, Massachusetts.
Prev. Close
17.7064
Open
17.3833
High
18.3875
Low
17.3
52 wk Range
14.57-49.97
Market Cap
1 100 M
Shares Outstanding
61 773 K
EPS
-1.19
Beta
2.6
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Obsidian Therapeutics, Inc. Common Stock data using free add-ons & libraries
Get Obsidian Therapeutics, Inc. Common Stock Fundamental Data
Obsidian Therapeutics, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -95 858 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Obsidian Therapeutics, Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-12
- EPS/Forecast: -1.635
Get Obsidian Therapeutics, Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Obsidian Therapeutics, Inc. Common Stock News
New
Zillow downgraded, Global Payments upgraded: Wall Street's top analyst calls
Zillow downgraded, Global Payments upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...
Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls
Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...
Obsidian, Galera to advance cell therapy following reverse merger
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Obsidian Therapeutics, a private biotechnology compan...
Galera Therapeutics, Obsidian Therapeutics Announces All-Stock Merger; Stock Up
(RTTNews) - Galera Therapeutics, Inc. (GRTX), a clinical-stage biopharmaceutical company developing a pan-NOS inhibitor for advanced breast cancer, has agreed to merge with privately held Obsidian The...
Get Obsidian Therapeutics, Inc. Common Stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
